Newsletter Archive
-
09.14.23 -- RNA-LNP Therapeutic Strategies | LNP Formulation, Scale-Up, IND-enabling Studies
9/14/2023
09/14/23 Drug Discovery Online Newsletter
-
09.13.23 -- Affinity Chromatography For mAbs, Mechanistic Modeling, And Polishing
9/13/2023
09/13/23 Drug Discovery Online Newsletter
-
09.12.23 -- Planning For Complexity And Risks In Drug Development And Supply
9/12/2023
09/12/23 Drug Discovery Online Newsletter
-
09.12.23 -- Targeting SORT1 To Unlock The Potential Of Peptide–Drug Conjugates In Oncology
9/12/2023
09/12/23 Drug Discovery Online Newsletter
-
09.07.23 -- Finding Solutions To Harness The Potential Of HPAPI Particles
9/7/2023
09/07/23 Drug Discovery Online Newsletter
-
09.05.23 -- The Growing Use Of Antibody Library Technologies In Drug Discovery
9/5/2023
09/05/23 Drug Discovery Online Newsletter
-
08.30.23 -- Futureproof The Design Of Your Biomanufacturing Capacity
8/30/2023
08/30/23 Drug Discovery Online Newsletter
-
08.29.23 -- The Global Landscape For Synthetic Biology In Biopharma Through 2035
8/29/2023
08/29/23 Drug Discovery Online Newsletter
-
08.22.23 -- Targeting Von Willebrand Factor With An RNA Aptamer To Treat Stroke
8/22/2023
08/22/23
-
08.21.23 -- Can Advances In Nanoparticle Engineering Technology Improve New Drug Candidate Success Rates?
8/21/2023
08/21/23 Drug Discovery Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more